Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleP454The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy.AuthorsGowran, A; Castiglioni, E; Rovina, D; Casalnuovo, F; Nigro, P; Spinelli, P; Visone, R; Rasponi, M; Redaelli, A; Pompilio, GSubjectsCANNABINOID receptors; MUSCULAR dystrophy treatment; TREATMENT of cardiomyopathiesPublicationCardiovascular Research, 2018, Vol 114, pS109ISSN0008-6363Publication typeAbstractDOI10.1093/cvr/cvy060.313